Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
US 20-F for the Eleven Months Ended 31 December 2019 US 20-F for the Eleven Months Ended 31 December 2019 July 8, 2020 By Christie Cope
Website Cookies This website uses cookies: Please see our Privacy Policy to understand how we use cookies. Okay, thanks
